PCK 12.5% 3.6¢ painchek ltd

Ann: Second Quarter Report FY 2016/17, page-32

  1. 3,541 Posts.
    lightbulb Created with Sketch. 223
    No that's not quite right. The efficacy was tested in the validation trial, and this implementation study tested that when two different testers apply the same test to the same dementia patient they get the same result. The result was better for patients at rest (100% agreement) compared to while moving (repositioning or walking). All patients had moderate to severe dementia.
 
watchlist Created with Sketch. Add PCK (ASX) to my watchlist
(20min delay)
Last
3.6¢
Change
0.004(12.5%)
Mkt cap ! $58.88M
Open High Low Value Volume
3.3¢ 3.6¢ 3.3¢ $67.31K 1.930M

Buyers (Bids)

No. Vol. Price($)
1 74 3.6¢
 

Sellers (Offers)

Price($) Vol. No.
3.8¢ 200000 1
View Market Depth
Last trade - 16.10pm 19/07/2024 (20 minute delay) ?
PCK (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.